Filtros de búsqueda

Lista de obras de

A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population

scientific journal article

Association study of 71 European Crohn's disease susceptibility loci in a Japanese population

artículo científico publicado en 2013

C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's disease

artículo científico publicado en 2013

Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

Effects of vedolizumab in Japanese patients with Crohn's disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses

scientific article published on 13 December 2019

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

artículo científico publicado en 2013

Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis.

artículo científico publicado en 2017

Evidence-based clinical practice guidelines for inflammatory bowel disease.

artículo científico publicado en 2018

First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis-results from a multicenter prospective randomized controlled trial and its post hoc analysis

artículo científico publicado en 2015

Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis

artículo científico publicado en 2017

Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries.

artículo científico publicado en 2018

Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan

artículo científico publicado en 2016

Sargramostim in patients with Crohn's disease: results of a phase 1-2 study

artículo científico publicado en 2009

Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies.

artículo científico publicado en 2018

Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

scientific article published on 26 February 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda